In 1,380 patients with anterior-circulation large-vessel occlusion stroke and successful thrombectomy reperfusion, tirofiban vs placebo increased 90-day functional independence (49% vs 43%; adjusted RR 1.15). Symptomatic ICH was numerically higher (12% vs 9%), not significant.
RCTn = 1,380
Huang et al. Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial